New Pharaoh CEO Amaza Reitmeier explains why now’s the time to take a leap and lead a CSF startup

In this episode of the DeviceTalks Weekly podcast, Amaza Reitmeier shares with Host Tom Salemi why she left the company she never thought she’d leave — Medtronic — to lead Pharaoh Neuro, a company developing a novel approach to treating stroke patients by removing harmful blood from cerebrospinal fluid. Reitmeier shares lessons from her own career and her mentors on timing big moves, learning what you don’t know, and why some of MedTech’s biggest opportunities remain hidden in plain sight. This episode is sponsored by DeviceTalks Minnesota. Register at Minnesota.DeviceTalks.com and use the code DTW25 to save 25% off the registration fee. Salemi and MassDevice Editor Chris Newmarker offer encouragement to exercising listeners while delivering this week’s Newmarker’s Newsmakers — including updates on cardiology companies, HistoSonics, Boston Scientific, Johnson & Johnson MedTech, Abbott, the Mayo Clinic, and WHOOP. *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players +

You can listen to New Pharaoh CEO Amaza Reitmeier explains why now’s the time to take a leap and lead a CSF startup online on Radio and Podcast. Open the player on this page to stream the available audio.

New Pharaoh CEO Amaza Reitmeier explains why now’s the time to take a leap and lead a CSF startup is an episode from DeviceTalks by DeviceTalks.

This episode is 00:56:49 long.

This episode was published on Apr 3, 2026.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from DeviceTalks when more episodes are available from the podcast feed.